MENU
+Compare
NVS
Stock ticker: NYSE
AS OF
Aug 28, 01:53 PM (EDT)
Price
$126.56
Change
-$0.32 (-0.25%)
Capitalization
244.82B

NVS Novartis AG Forecast, Technical & Fundamental Analysis

Novartis develops and manufactures innovative drugs... Show more

NVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NVS with price predictions
Aug 27, 2025

Momentum Indicator for NVS turns positive, indicating new upward trend

NVS saw its Momentum Indicator move above the 0 level on August 11, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned positive. In of the 83 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for NVS just turned positive on August 11, 2025. Looking at past instances where NVS's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

NVS moved above its 50-day moving average on August 11, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for NVS crossed bullishly above the 50-day moving average on August 15, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NVS advanced for three days, in of 342 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for NVS moved out of overbought territory on August 25, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NVS broke above its upper Bollinger Band on August 13, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for NVS entered a downward trend on August 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.851) is normal, around the industry mean (9.451). P/E Ratio (18.497) is within average values for comparable stocks, (23.804). Projected Growth (PEG Ratio) (1.382) is also within normal values, averaging (1.849). Dividend Yield (0.032) settles around the average of (0.027) among similar stocks. P/S Ratio (4.585) is also within normal values, averaging (3.415).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NVS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
NVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NVS is expected to report earnings to fall 8.68% to $2.21 per share on October 28

Novartis AG NVS Stock Earnings Reports
Q3'25
Est.
$2.21
Q2'25
Beat
by $0.07
Q1'25
Beat
by $0.20
Q4'24
Beat
by $0.16
Q3'24
Beat
by $0.12
The last earnings report on July 17 showed earnings per share of $2.42, beating the estimate of $2.35. With 84.82K shares outstanding, the current market capitalization sits at 244.82B.
A.I.Advisor
published Dividends

NVS paid dividends on March 20, 2023

Novartis AG NVS Stock Dividends
А dividend of $3.70 per share was paid with a record date of March 20, 2023, and an ex-dividend date of March 09, 2023. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of health care and nutritional products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Lichtstrasse 35
Phone
+41 613241111
Employees
76057
Web
https://www.novartis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IWP142.430.79
+0.56%
iShares Russell Mid-Cap Growth ETF
PCGG12.190.04
+0.29%
Polen Capital Global Growth ETF
BUFF48.25N/A
N/A
Innovator Laddered Allc Pwr Bfr ETF™
NXTE35.10-0.25
-0.69%
AXS Green Alpha ETF
EZET34.68-0.26
-0.74%
Franklin Ethereum ETF

NVS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NVS has been closely correlated with GSK. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVS jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVS
1D Price
Change %
NVS100%
+0.20%
GSK - NVS
68%
Closely correlated
+0.20%
AZN - NVS
61%
Loosely correlated
-0.15%
PFE - NVS
57%
Loosely correlated
+0.60%
JNJ - NVS
54%
Loosely correlated
+0.17%
SNY - NVS
54%
Loosely correlated
-0.38%
More

Groups containing NVS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVS
1D Price
Change %
NVS100%
+0.20%
NVS
(2 stocks)
97%
Closely correlated
-0.49%